AKT1 and breast carcinoma: According to previous studies, some known inhibitor particularly AKT inhibitor LY294002 could potently suppress breast cancer proliferation, migration and invasion [17, 24, 25], therefore we also included LY294002 (10 μM) as positive control in the following cell proliferation and migration assays.